Amphastar Pharmaceuticals finally has the FDA's blessing. After a protracted battle marked by lawsuits against the agency and conflicts of interest allegations, the ...

LONDON, June 5 (Reuters) - Doctors in Europe can continue to use Sanofi-Aventis SA's heparin medicine Lovenox, despite low levels of contamination found in some batches of the product, the European ...

You know those movie scenes in which our hero is moving downriver in a boat, only to suddenly happen upon an enormous waterfall? We have to watch while the hero frantically paddles upstream or makes ...

Sanofi-Aventis has received approval from US regulators for expanded use of its blockbuster anticoagulant Lovenox as a treatment for severe heart attacks. Sanofi-Aventis has received approval from US ...

Sanofi-Aventis is suing FDA, claiming the agency acted inconsistently and unlawfully in approving a generic version of its anticoagulant Lovenox. The approval of the generic, developed by Momenta ...

Unlike unfractionated heparin (UFH), the low-molecular-weight heparin enoxaparin (Lovenox) is excreted mainly by the kidneys. To determine whether this characteristic heightens bleeding risk in ...

LONDON, July 8 (Reuters) - Bayer AG's experimental pill rivaroxaban is significantly more effective than standard injections of Lovenox in preventing blood clots after knee surgery, researchers said ...